Polycythemia Vera Post-polycythemia Vera Myelofibrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-05-15
Clinical Trial Update: Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis [Phase 2]
Phase 2 trial evaluating nivolumab in various myelofibrosis-related conditions, terminated with posted results.